Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa

Condition:   Tuberculosis Interventions:   Biological: MTBVAC;   Biological: BCG Sponsors:   Biofabri, S.L;   TuBerculosis Vaccine Initiative;   University of Cape Town;   Institut Pasteur de Madagascar;   Biomedical Research Center EPLS;   Universidad de Zaragoza;   University of Stellenbosch;   University of KwaZulu;   Wits Health Consortium (Pty) Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials